These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 30772646)

  • 21. Procaspase-activating compound-1 induces apoptosis in Trypanosoma cruzi.
    de Castro E; Reus TL; de Aguiar AM; Ávila AR; de Arruda Campos Brasil de Souza T
    Apoptosis; 2017 Dec; 22(12):1564-1577. PubMed ID: 29058102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concomitant Benznidazole and Suramin Chemotherapy in Mice Infected with a Virulent Strain of Trypanosoma cruzi.
    Santos EC; Novaes RD; Cupertino MC; Bastos DS; Klein RC; Silva EA; Fietto JL; Talvani A; Bahia MT; Oliveira LL
    Antimicrob Agents Chemother; 2015 Oct; 59(10):5999-6006. PubMed ID: 26169419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis of novel quinine analogs and evaluation of their effects on Trypanosoma cruzi.
    Ceole LF; Gandhi H; Villamizar LH; Soares MJ; O'Sullivan TP
    Future Med Chem; 2018 Feb; 10(4):391-408. PubMed ID: 29380636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and characterization of poly(amido amine) dendrimer containing fluorene as a core chromophore.
    Lee JW; Kim HJ; Han SC; Kim JH; Jin SH
    J Nanosci Nanotechnol; 2008 Sep; 8(9):4635-9. PubMed ID: 19049074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trypanosoma cruzi benznidazole susceptibility in vitro does not predict the therapeutic outcome of human Chagas disease.
    Moreno M; D'ávila DA; Silva MN; Galvão LM; Macedo AM; Chiari E; Gontijo ED; Zingales B
    Mem Inst Oswaldo Cruz; 2010 Nov; 105(7):918-24. PubMed ID: 21120364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of 2-hydroxy-3-phenylsulfanylmethyl-[1,4]-naphthoquinone derivatives against different Trypanosoma cruzi discrete type units: Identification of a promising hit compound.
    Lara LS; Moreira CS; Calvet CM; Lechuga GC; Souza RS; Bourguignon SC; Ferreira VF; Rocha D; Pereira MCS
    Eur J Med Chem; 2018 Jan; 144():572-581. PubMed ID: 29289882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polyamidoamine dendrimers used as solubility enhancers of ketoprofen.
    Yiyun C; Tongwen X; Rongqiang F
    Eur J Med Chem; 2005 Dec; 40(12):1390-3. PubMed ID: 16226353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selenium-containing analogues of WC-9 are extremely potent inhibitors of Trypanosoma cruzi proliferation.
    Chao MN; Storey M; Li C; Rodríguez MG; Di Salvo F; Szajnman SH; Moreno SNJ; Docampo R; Rodriguez JB
    Bioorg Med Chem; 2017 Dec; 25(24):6435-6449. PubMed ID: 29107437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel Imidazo[4,5-c][1,2,6]thiadiazine 2,2-dioxides as antiproliferative trypanosoma cruzi drugs: Computational screening from neural network, synthesis and in vivo biological properties.
    Guerra A; Gonzalez-Naranjo P; Campillo NE; Varela J; Lavaggi ML; Merlino A; Cerecetto H; González M; Gomez-Barrio A; Escario JA; Fonseca-Berzal C; Yaluf G; Paniagua-Solis J; Páez JA
    Eur J Med Chem; 2017 Aug; 136():223-234. PubMed ID: 28499168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Click dendrimers and triazole-related aspects: catalysts, mechanism, synthesis, and functions. A bridge between dendritic architectures and nanomaterials.
    Astruc D; Liang L; Rapakousiou A; Ruiz J
    Acc Chem Res; 2012 Apr; 45(4):630-40. PubMed ID: 22148925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toxic effects of natural piperine and its derivatives on epimastigotes and amastigotes of Trypanosoma cruzi.
    Ribeiro TS; Freire-de-Lima L; Previato JO; Mendonça-Previato L; Heise N; de Lima ME
    Bioorg Med Chem Lett; 2004 Jul; 14(13):3555-8. PubMed ID: 15177472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PAMAM dendrimers and branched polyethyleneglycol (nanoparticles) prodrugs of (-)-beta-D-(2R, 4R)-dioxolane-thymine (DOT) and their anti-HIV activity.
    Liang Y; Narayanasamy J; Rapp KL; Schinazi RF; Chu CK
    Antivir Chem Chemother; 2006; 17(6):321-9. PubMed ID: 17249246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of Trypanosoma cruzi hexokinase by bisphosphonates.
    Hudock MP; Sanz-Rodríguez CE; Song Y; Chan JM; Zhang Y; Odeh S; Kosztowski T; Leon-Rossell A; Concepción JL; Yardley V; Croft SL; Urbina JA; Oldfield E
    J Med Chem; 2006 Jan; 49(1):215-23. PubMed ID: 16392806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation and evaluation of PAMAM dendrimer-based polymer gels physically cross-linked by hydrogen bonding.
    Cong H; Zhou L; Meng Q; Zhang Y; Yu B; Shen Y; Hu H
    Biomater Sci; 2019 Sep; 7(9):3918-3925. PubMed ID: 31322162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidermal growth factor-PEG functionalized PAMAM-pentaethylenehexamine dendron for targeted gene delivery produced by click chemistry.
    Yu H; Nie Y; Dohmen C; Li Y; Wagner E
    Biomacromolecules; 2011 Jun; 12(6):2039-47. PubMed ID: 21491906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aryl- or heteroaryl-based hydrazinylphthalazine derivatives as new potential antitrypanosomal agents.
    Romero AH; Rodríguez J; García-Marchan Y; Leañez J; Serrano-Martín X; López SE
    Bioorg Chem; 2017 Jun; 72():51-56. PubMed ID: 28359970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimization of anti-Trypanosoma cruzi oxadiazoles leads to identification of compounds with efficacy in infected mice.
    dos Santos Filho JM; Moreira DR; de Simone CA; Ferreira RS; McKerrow JH; Meira CS; Guimarães ET; Soares MB
    Bioorg Med Chem; 2012 Nov; 20(21):6423-33. PubMed ID: 23006639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of a new anti-T. cruzi metallic compound based on palladium.
    Mosquillo MF; Bilbao L; Hernández F; Machado I; Gambino D; Garat B; Pérez-Díaz L
    Biometals; 2018 Dec; 31(6):961-974. PubMed ID: 30259247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design considerations for PAMAM dendrimer therapeutics.
    Goonewardena SN; Kratz JD; Zong H; Desai AM; Tang S; Emery S; Baker JR; Huang B
    Bioorg Med Chem Lett; 2013 May; 23(10):2872-5. PubMed ID: 23583511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mexican Trypanosoma cruzi isolates: in vitro susceptibility of epimastigotes to anti-trypanosoma cruzi drugs and metacyclic forms to complement-mediated lysis.
    León-Pérez F; Gómez-Garcia L; Alejandre-Aguilar R; López R; Monteón VM
    Vector Borne Zoonotic Dis; 2007; 7(3):330-6. PubMed ID: 17760512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.